Families considering GLP-1 therapy for a teenager should understand that any such treatment falls outside formal FDA authorization and requires a thorough risk-benefit discussion with a pediatric endocrinologist or obesity specialist
Key results and Safety After 68 weeks of treatment, people taking cagrilintide 2.4 mg once weekly lost an average of 11.8% of their body weight, which was about 12.5 kilograms
Endocrinology (2009) 150(8):365563
Novo Nordisks GLP-1 success is a major factor in this, as with a market value of $570 billion it is now greater than the entire Danish economy
Every scoop delivers a powerful combination of our advanced superfood blend and GOS, our prebiotic-fiber formula, to help nourish your microbiome and fuel the healthy flora in your intestinebecause when you look after your gut microbiota, your skin will flourish
Manufacturer Procter & Gamble Product Disclaimer: MARTIN'S is committed to providing accurate nutritional information to its customers
,aspect=ignore)
